Electrosurgical and Laser Therapy Tools for the Management of Malignant Central Airway Obstructions.

Clicks: 390
ID: 29049
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #12 of 27 articles by views in chest

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Central airway obstruction (CAO) is associated with significant morbidity and increased mortality. Bronchoscopic electrosurgical and laser ablative tools have proven to be safe and effective instruments for the treatment of malignant CAO. While therapeutic modalities such as electrocautery, argon plasma coagulation (APC), and laser have been utilized for decades, additional tools including radiofrequency ablation (RFA) catheters continue to be developed for the treatment of CAO. These modalities are considered safe in the hands of experienced operators, though serious complications can occur. This review describes the use of various electrosurgical and laser therapy tools used for the treatment of malignant CAO along with the specific advantages and disadvantages of each device.
Reference Key
mahajan2019electrosurgicalchest Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mahajan, Amit K;Ibrahim, Omar;Perez, Ricardo;Oberg, Catherine L;Majid, Adnan;Folch, Erik;
Journal chest
Year 2019
DOI
S0012-3692(19)33463-4
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.